文献速递乳腺癌放疗放疗物理与技术

阻断IL4/IL13介导的STAT6磷酸化可减少巨噬细胞M2极化并逆转炎性乳腺癌的巨噬细胞相关放疗抵抗

Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-12-07

该研究探讨巨噬细胞极化对炎性乳腺癌(IBC)细胞放疗反应的影响及调控巨噬细胞可塑性能否改变放疗反应。方法为将人THP-1单核细胞系及外周血原代单核细胞分化为巨噬细胞并极化为M1或M2表型,与IBC细胞系(SUM149、KPL4、MDA-IBC3、SUM190)非接触共培养24小时后照射(0、2、4、6 Gy)。结果显示M1极化巨噬细胞共培养介导IBC细胞放疗敏感,而M2极化巨噬细胞共培养介导放疗抵抗;靶向STAT6 SH2结构域的磷酸肽模拟物PM37可预防和逆转IL4/IL13介导的STAT6磷酸化(Tyr641)并降低M2极化标志物表达;PM37预处理M2-THP1巨噬细胞可减少其诱导的IBC细胞放疗抵抗。结论提示PM37抑制巨噬细胞M2极化可通过下调PRKCZ预防IBC放疗抵抗。

要点

  • M1极化巨噬细胞共培养介导IBC细胞放疗敏感,M2极化巨噬细胞共培养介导放疗抵抗。
  • PM37可预防和逆转IL4/IL13介导的STAT6磷酸化(Tyr641)并降低M2标志物表达。
  • PM37预处理M2巨噬细胞可减少其诱导的IBC细胞放疗抵抗,并与下调PRKCZ相关。

核心结论

  • 抑制巨噬细胞M2极化(如PM37靶向STAT6)可通过下调PRKCZ预防炎性乳腺癌的放疗抵抗。

研究设计与样本

  • 研究使用人THP-1单核细胞系及外周血原代单核细胞分化为巨噬细胞并极化为M1或M2表型。
  • 极化巨噬细胞与IBC细胞系(SUM149、KPL4、MDA-IBC3、SUM190)非接触共培养24小时后照射(0、2、4、6 Gy)。
  • 通过Western blot检测STAT6磷酸化(Tyr641),qPCR检测M2极化标志物(CD206、fibronectin、CCL22),激酶抗体芯片进行靶向蛋白组学分析。

主要发现

  • IL4/IL13处理后M2极化巨噬细胞的M2标志物表达高于对照(M0)或M1极化巨噬细胞。
  • 与M1极化THP-1巨噬细胞共培养介导IBC细胞放疗敏感,而与M2极化巨噬细胞共培养介导放疗抵抗。
  • PM37预防和逆转IL4/IL13介导的STAT6磷酸化(Tyr641)并降低M2极化标志物表达。
  • PM37预处理M2-THP1巨噬细胞减少共培养后其对IBC细胞诱导的放疗抵抗。
  • KPL4细胞仅在M2-THP1共培养后诱导PRKCZ,PM37预处理可阻止;PRKCZ敲低KPL4细胞在M2-THP1共培养后放疗抵抗降低。

临床怎么用

  • 靶向STAT6磷酸化(Tyr641)以抑制巨噬细胞M2极化,可能作为减轻IBC放疗抵抗的策略。
  • PM37预处理M2巨噬细胞可减少其诱导的IBC细胞放疗抵抗,提示调控巨噬细胞可塑性可改变放疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the role of macrophage polarization on the response of inflammatory breast cancer (IBC) cells to radiation and whether modulation of macrophage plasticity can alter radiation response. METHODS AND MATERIALS: The human THP-1 monocyte cell line and primary human monocytes isolated from peripheral blood mononuclear cells were differentiated into macrophages and polarized to either an "antitumor" (M1) or a "protumor" (M2) phenotype. These polarized macrophages were co-cultured with IBC cells (SUM149, KPL4, MDA-IBC3, or SUM190) without direct contact for 24 hours, then subjected to irradiation (0, 2, 4, or 6 Gy). Interleukin (IL)4/IL13-induced activation of STAT6 signaling was measured by Western blotting of phospho-STAT6 (Tyr641), and expression of M2 polarization gene markers (CD206, fibronectin, and CCL22) was measured by quantitative polymerase chain reaction. RESULTS: Expression of M2 polarization markers was higher in M2-polarized macrophages after IL4/IL13 treatment than in control (M0) or M1-polarized macrophages. Co-culture of IBC cell lines with M1-polarized THP-1 macrophages mediated radiosensitivity of IBC cells, whereas co-culture with M2-polarized macrophages mediated radioresistance. Phosphopeptide mimetic PM37, targeting the SH2 domain of STAT6, prevented and reversed IL4/IL13-mediated STAT6 phosphorylation (Tyr641) and decreased the expression of M2 polarization markers. Pretreatment of M2-THP1 macrophages with PM37 reduced the radioresistance they induced in IBC cells after co-culture. Targeted proteomics analysis of IBC KPL4 cells using a kinase antibody array revealed induction of protein kinase C zeta (PRKCZ) in these cells only after co-culture with M2-THP1 macrophages, which was prevented by PM37 pretreatment. KPL4 cells with stable short hairpin RNA knockdown of PRKCZ exhibited lower radioresistance after M2-THP1 co-culture. CONCLUSIONS: These data suggest that inhibition of M2 polarization of macrophages by PM37 can prevent radioresistance of IBC by down-regulating PRKCZ.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Rahal OM, Wolfe AR, Mandal PK, et al. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 29485045. doi:10.1016/j.ijrobp.2017.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。